Abstract
Background
In addition to other variables associated with PRP injections for Knee Osteoarthritis (OA), some confusion exists about the role of exogenous activators. The current study looks at matched groups getting PRP injections with or without activator (Calcium gluconate) in early knee OA patients.
Methods
Patients of early OA knee meeting inclusion criteria were randomly divided into 2 groups; Group A (43 patients) received 8 ml PRP injection alone, and Group B (48 patients) received 8 ml PRP along with 2 ml Calcium gluconate as activator. The patients were evaluated at baseline, 6 weeks, 3 months and 6 months for WOMAC Pain and Total WOMAC scores; secondary variables assessed were VAS score and patient satisfaction.
Results
The baseline characteristics of both groups were comparable. Leucocyte-depleted PRP with 5 times concentration and average absolute platelet numbers of 7.144 billion per knee was injected. Mean Pain WOMAC scores decreased in both groups from baseline (group A—8.68, group B—9.09) to final follow-up (group A—4.67, group B—5.11). Similarly, Mean Total WOMAC scores decreased from baseline (group A—37.81, group B—37.41) to (group A—21, group B—21.36) at the final follow-up in both groups. There was no significant difference between both groups, and both showed similar trends. Similar findings were noted for VAS scores. Patient satisfaction was also not different (group A, 90.69%, group B, 89.58%) at the end of 6 months.
Conclusion
Our study concluded doubtful role of adding exogenous activator to PRP preparation.
Similar content being viewed by others
Data Availability
Not applicable.
Code Availability
Not applicable.
References
Wearing, S. C., Hennig, E. M., Byrne, N. M., Steele, J. R., & Hills, A. P. (2006). Musculoskeletal disorders associated with obesity: A biomechanical perspective. Obesity Reviews: Official Journal of the International Association for the Study of Obesity, 7(3), 239–250.
Langworthy, M. J., Saad, A., & Langworthy, N. M. (2010). Conservative treatment modalities and outcomes for osteoarthritis: The concomitant pyramid of treatment. The Physician and Sportsmedicine, 38(2), 133–145.
Pietrzak, W. S., & Eppley, B. L. (2005). Platelet rich plasma: Biology and new technology. The Journal of Craniofacial Surgery, 16(6), 1043–1054.
Patel, S., Dhillon, M. S., Aggarwal, S., Marwaha, N., & Jain, A. (2013). Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: A prospective, double-blind, randomized trial. American Journal of Sports Medicine, 41(2), 356–364.
Görmeli, G., Görmeli, C. A., Ataoglu, B., Çolak, C., Aslantürk, O., & Ertem, K. (2017). Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: A randomized, double-blind, placebo-controlled trial. Knee Surgery, Sports Traumatology, Arthroscopy, 25(3), 958–965.
Li, M., Zhang, C., Ai, Z., Yuan, T., Feng, Y., & Jia, W. (2011). Therapeutic effectiveness of intra-knee-articular injection of platelet-rich plasma on knee articular cartilage degeneration. Journal of Reparative and Reconstructive Surgery, 25(10), 1192–1196.
Filardo, G., Kon, E., Pereira Ruiz, M. T., Vaccaro, F., Guitaldi, R., Di Martino, A., et al. (2012). Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: Single- versus double-spinning approach. Knee Surgery, Sports Traumatology, Arthroscopy, 20(10), 2082–2091.
Duymus, T. M., Mutlu, S., Dernek, B., Komur, B., Aydogmus, S., & Kesiktas, F. N. (2017). Choice of intra-articular injection in treatment of knee osteoarthritis: Platelet-rich plasma, hyaluronic acid or ozone options. Knee Surgery, Sports Traumatology, Arthroscopy, 25(2), 485–492.
Spaková, T., Rosocha, J., Lacko, M., Harvanová, D., & Gharaibeh, A. (2012). Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. American Journal of Physical Medicine and Rehabilitation, 91(5), 411–417.
Raeissadat, S. A., Rayegani, S. M., Hassanabadi, H., Fathi, M., Ghorbani, E., Babaee, M., et al. (2015). Knee osteoarthritis injection choices: Platelet- rich plasma (prp) versus hyaluronic acid (A one-year randomized clinical trial). Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 8, 1–8.
Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. Journal of Pharmacology and Pharmacotherapeutics, 1(2), 100–107.
Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., et al. (1986). Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis & Rheumatology, 29 (8), 1039–49.
Kohn, M. D., Sassoon, A. A., & Fernando, N. D. (2016). Classifications in brief: Kellgren-Lawrence classification of osteoarthritis. Clinical Orthopaedics, 474(8), 1886–1893.
Tubach, F., Wells, G. A., Ravaud, P., & Dougados, M. (2005). Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: Methodological issues. Journal of Rheumatology, 32(10), 2025–2029.
Kon, E., Mandelbaum, B., Buda, R., Filardo, G., Delcogliano, M., Timoncini, A., et al. (2011). Platelet-rich plasma intra-articular injection versus hyaluronic acid visco supplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis. Arthroscopy, 27(11), 1490–1501.
Chang, K.-V., Hung, C.-Y., Aliwarga, F., Wang, T.-G., Han, D.-S., & Chen, W.-S. (2014). Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: A systematic review and meta-analysis. Archives of Physical Medicine and Rehabilitation, 95(3), 562–575.
Laudy, A. B. M., Bakker, E. W. P., Rekers, M., & Moen, M. H. (2015). Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: A systematic review and meta-analysis. British Journal of Sports Medicine, 49(10), 657–672.
Shen, L., Yuan, T., Chen, S., Xie, X., & Zhang, C. (2017). The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: Systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Surgery, 12, 16.
Cavallo, C., Roffi, A., Grigolo, B., Mariani, E., Pratelli, L., Merli, G., et al. (2016). Platelet-Rich plasma: The choice of activation method affects the release of bioactive molecules. BioMed Research International, 2016, 6591717.
Mishra, A., Harmon, K., Woodall, J., & Vieira, A. (2012). Sports medicine applications of platelet-rich plasma. Current Pharmaceutical Biotechnology, 13(7), 1185–1195.
DeLong, J. M., Russell, R. P., & Mazzocca, A. D. (2012). Platelet-rich plasma: The PAW classification system. Arthroscopy, 28(7), 998–1009.
Patel, S., Gahlaut, S., Thami, T., Chouhan, D. K., Jain, A., & Dhillon, M. S. (2024). Comparison of conventional dose versus superdose platelet-rich plasma for knee osteoarthritis: A prospective, triple-blind, randomized clinical trial. Orthopaedic Journal of Sports Medicine, 12(2), 23259671241227864.
Bansal, H., Leon, J., Pont, J. L., Wilson, D. A., Bansal, A., Agarwal, D., et al. (2021). Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long-term clinical efficacy. Science and Reports, 11(1), 3971.
Chouhan, D. K., Dhillon, M. S., Patel, S., Bansal, T., Bhatia, A., & Kanwat, H. (2019). Multiple platelet- rich plasma injections versus single platelet-rich plasma injection in early osteoarthritis of the knee: An experimental study in a guinea pig model of early knee osteoarthritis. American Journal of Sports Medicine, 47(10), 2300–2307.
Dhillon, M. S., Patel, S., & Bansal, T. (2019). Improvising PRP for use in osteoarthritis knee- upcoming trends and futuristic view. Journal of Clinical Orthopaedics and Trauma, 10(1), 32–35.
Kon, E., Buda, R., Filardo, G., Di Martino, A., Timoncini, A., Cenacchi, A., et al. (2010). Platelet-rich plasma: Intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surgery, Sports Traumatology, Arthroscopy, 18(4), 472–479.
Funding
No funding was required.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
On behalf of all authors, the corresponding author would like to declare there are no potential conflicts of interest.
Ethics Approval
This kind of study does not require ethical approval.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rai, S., Patel, S., Chouhan, D.K. et al. Is There a Need for an Exogenous Activator Along with PRP for Early Knee Osteoarthritis? A Triple-Blinded Randomized Control Trial. JOIO (2024). https://doi.org/10.1007/s43465-024-01159-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s43465-024-01159-7